Working... Menu

Secukinumab Safety and Efficacy in JPsA and ERA

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03031782
Recruitment Status : Recruiting
First Posted : January 26, 2017
Last Update Posted : March 11, 2019
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : October 23, 2019
  Estimated Study Completion Date : December 30, 2020